Growing community of inventors

San Francisco, CA, United States of America

Chris Dong

Average Co-Inventor Count = 7.14

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 6

Chris DongKurt Scheinpflug (5 patents)Chris DongNikhil Pargaonkar (5 patents)Chris DongRobert Duck (3 patents)Chris DongRaymond H Schmidt (3 patents)Chris DongJeremy Frank (3 patents)Chris DongRobert Azevedo (3 patents)Chris DongPeter Bjeletich (3 patents)Chris DongHiren Patel (3 patents)Chris DongNikolaus Leist (3 patents)Chris DongAi Ling Ching (2 patents)Chris DongDawn Adkin (2 patents)Chris DongChris Dong (5 patents)Kurt ScheinpflugKurt Scheinpflug (6 patents)Nikhil PargaonkarNikhil Pargaonkar (5 patents)Robert DuckRobert Duck (21 patents)Raymond H SchmidtRaymond H Schmidt (20 patents)Jeremy FrankJeremy Frank (11 patents)Robert AzevedoRobert Azevedo (10 patents)Peter BjeletichPeter Bjeletich (7 patents)Hiren PatelHiren Patel (4 patents)Nikolaus LeistNikolaus Leist (3 patents)Ai Ling ChingAi Ling Ching (5 patents)Dawn AdkinDawn Adkin (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Otsuka Pharmaceutical Company, Limited (4 from 846 patents)

2. Other (1 from 832,843 patents)


5 patents:

1. 11793419 - Methods for manufacturing capsules with ingestible event markers

2. 11684605 - Lisinopril compositions with an ingestible event marker

3. 11529071 - Methods for manufacturing capsules with ingestible event markers

4. 11166939 - Lisinopril compositions with an ingestible event marker

5. 10820831 - Methods for manufacturing capsules with ingestible event markers

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/25/2025
Loading…